Overview
Lirui Dai practices in Chengdu, China. Dai is highly rated in 4 conditions, according to our data. Their top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.
Their clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AstrocytomaDai isAdvanced. Learn about Astrocytoma.
- GlioblastomaDai isAdvanced. Learn about Glioblastoma.
- GliomaDai isAdvanced. Learn about Glioma.
- Gliomatosis CerebriDai isAdvanced. Learn about Gliomatosis Cerebri.
- Experienced
- Brain TumorDai isExperienced. Learn about Brain Tumor.
- Cervical SpondylosisDai isExperienced. Learn about Cervical Spondylosis.
- CraniopharyngiomaDai isExperienced. Learn about Craniopharyngioma.
- EmpyemaDai isExperienced. Learn about Empyema.
- Familial Colorectal Cancer